| 摘要 |
DISCLOSED ARE NOVEL COMPOUNDS OF THE FORMULA ALSO DISCLOSED ARE PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUNDS OF FORMULA I.ALSO DISCLOSED ARE METHODS OF TREATING VARIOUS DISEASES OR CONDITIONS, SUCH AS, FOR EXAMPLE, ALLERGY, ALLERGY-INDUCED AIRWAY RESPONSES, AND CONGESTION (E.G., NASAL CONGESTION) USING THE COMPOUNDS OF FORMULA I.ALSO DISCLOSED ARE METHODS OF TREATING VARIOUS DISEASES OR CONDITIONS, SUCH AS, FOR EXAMPLE, ALLERGY, ALLERGY-INDUCED AIRWAY RESPONSES, AND CONGESTION (E.G., NASAL CONGESTION) USING THE COMPOUNDS OF FORMULA I IN COMBINATION WITH A H1 RECEPTOR ANTAGONIST.
|
| 申请人 |
SCHERING CORPORATION;PHARMACOPEIA DRUG DISCOVERY, INC. |
发明人 |
ROSENBLUM, STUART B.;MCCORMICK, KEVIN, D.;BALDWIN, JOHN, J.;LI, GE.;ZENG, QINGBEI;MUTAHI, MWANGI WA;ASLANIAN, ROBERT, G.;TING, PAULINE, C.;SHIH, NENG-YANG;SOLOMON, DANIEL, M.;CAO, JIANHUA;VACCARO, HENRY, A. |
